by investoropportunity | Mar 15, 2023 | Company Research, Health, Home Page Feature Articles, Technology, Uncategorized
PharmAla is the first for-profit company to synthesize clinical-grade (GMP) MDMA and make it available for sale to both researchers and qualified patients. PharmAla will increasingly develop a target on its back for acquisition and we expect a rise in marketcap via...
by investoropportunity | Nov 10, 2022 | Blockchain, Uncategorized
This synopsis was provided to us when asked for a summary of what went wrong with FTX. Bitcoin was invented because Satoshi saw how broken our current financial system was, and still is. But the crypto industry as a whole has forgotten this and has moved ever closer...
by investoropportunity | Oct 11, 2022 | Home Page Articles of Insight, Industry & Services, Uncategorized, Utilities Telecom Networks
AWK is a steadily growing cash-cow via regular utility rate increases, new contracts, and annual targeted acquisitions. AWK is also steady dividend payer; today yielding 2% — each year AWK raises the dividends per share, meaning greater compound returns in the...
by investoropportunity | Sep 26, 2022 | Company Research, Energy, Home Page Articles of Insight, Industry & Services, Technology, Uncategorized, Utilities Telecom Networks
NuScale’s VOYGR Power Module which can generate up to 77 MW, the smallest light water reactors in the world. A client can add modules over time as power needs grow. The current market-cap relative to potential market appears undervalued. NuScale Power (SMR)...
by investoropportunity | Sep 23, 2022 | Basic Materials, Company Research, Home Page Articles of Insight, Mining, Uncategorized
Best-of-breed fertilizer stock — Nutrien is looking at sales of ~$40 B this 2022 (43.6% higher than in 2021), profit should excel; in Q2-2022 Nutrien produced nearly as much free cash flow as it did in all of 2021. Looking for exposure to a hot commodity sector...
Recent Comments